1/73
Looks like no tags are added yet.
Potential Solutions to Behavioral Health Workforce Shortage:
1. ____ health to expand reach in underserved areas
2. integrated care models linking mental health with ___ ___
telebehavioral, primary care
Potential Solutions to Behavioral Health Workforce Shortage:
3. leveraging health support workers and expanding ___ ___ ___
scope of practice
Potential Solutions to Behavioral Health Workforce Shortage:
4. accelerated ___ programs
5. ___ reforms to improve reimbursement and retention incentives
training, policy
Components of Behavioral Health Assessment
1. ___ ___ (conducted first, captures full scope of patient's presentation)
intake assessment
Components of Behavioral Health Assessment
2. ___ ___ ____ ( = psychiatric physical exam)
mental status exam
Components of Behavioral Health Assessment
3. ____ ___ tools (provide quantitative symptom data, support early detection/triage in primary care, monitor response to treatment)
standardized screening
Domains of Mental Status Exam (MSE)
1. ___ (grooming, hygiene, clothing, apparent age, physical features)
2. ___/psychomotor activity (eye contact, posture, etc)
3. ___ (rate, volume, tone, etc)
appearance, behavior, speech
Domains of MSE
4. ____ (emotional state)
5. ___ (observable emotional expression)
6. thought ___ (organization and flow of ideas)
mood, affect, process
Domains of MSE
7. thought ___ (delusions, obsessions, etc)
8. ___ (hallucinations, illusions)
content, perceptions
Domains of MSE
9. ____/sensorium (orientation, attention, memory, etc)
10. ____/____
cognition, insight/judgement
Mental Health Screening Tools
-questionnaires designed to detect potential mental health conditions
-key features: ___, standardized, validates, objectively scored, free/widely available
brief
Mental Health Screening Tools-Advantages
1. provide ___ warning systems that identify people who need further evaluation
2. these tools can track symptom ___ over time
early, severity
Mental Health Screening Tools-Advantages
3. these tools provide ways to facilitate ___ about mental health with healthcare providers
4. are instruments to measure treatment ___
conversations, response
Mental Health Screening Tools-Disadvantages
1. these tools are not ____
2. these tools are not substitutes for ___ evaluation
diagnostic, professional
Mental Health Screening Tools-Disadvantages
3. these tools are not 100% ___
4. these tools do not help develop ____ ___
accurate, treatment plans
Components of Screening Tool Design
-___ of symptoms
-___ of symptoms
-__ of symptoms
-functional impairment
frequency, severity, duration
Mental Health Screening Tools
-If minimal/no symptoms → no intervention needed
-If mild symptoms → monitor/lifestyle interventions
-If moderate → recommend ___ ___
-If severe → recommend professional help ____
professional evaluation, immediately
Role of Pharmacist
1. support ____ detection/triage
2. ____/optimize drug therapy
3. monitor ___ of drug therapy
4. monitor __ ___ of drug therapy
early, initiate, effectiveness, adverse effects
____-___ is a screening tool for depression that contains the first 2 questions of the PHQ-9
PHQ-2
PHQ-2
-advantage → takes ___ ___
-limitation → lower ___ than PHQ-9
-cut-off → score ≥__ suggests possible depression and warrants full PHQ-9 administration
30 seconds, specificity, 3
PHQ-2-Preferred Use
-first-line screening for ___ clinical settings
-annual wellness visits with ___ time
-____-scale population screening
busy, limited, large
____-___ is the gold standard screening tool for depression that measures the presence and severity of symptoms over the past 2 weeks based on DSM-5 criteria for MDD
PHQ-9
PHQ-9
-score range from 0-27
-score ≥____ indicated MDD and is the cutoff for clinical action
10
PHQ-9
-question 9 is critical - asks about thoughts of death/self harm - if any positive response to this question, immediate ___ assessment required
safety
PHQ-9-Advantages
-brief
-validated across ___ populations; available in 80+ language
-directly maps to ___ depression diagnostic criteria
diverse, DSM-5
PHQ-9-Disadvantages
-relies on __-___ (so patients may underreport or overreport symptoms)
-doesn't ___ between types of depression
-___ factors may influence responses
self-reporting, differentiate, cultural
PHQ-9-Preferred Use
-___ MDD screening in adults
-patients with ___ medical conditions
-monitoring treatment ___
annual, chronic, response
Geriatric Depression Scale-15
-relies on __-__, requires yes/no answers
self-reporting
Geriatric Depression Scale-15
-cut-off → score ≥__ indicates possible depression
5
Geriatric Depression Scale-15-Preferred Use
-healthy ___
-medically ___ patients
-those with mild-moderate cognitive impairment
seniors, ill
Cornell Scale for Depression in Dementia
-includes both interview with ___ AND interview with ___
patient, caregiver
Cornell Scale for Depression in Dementia
-cut-off → score >__ indicates possible depression
6
Cornell Scale for Depression in Dementia-Preferred Use
-patients with ___
dementia
Beck-Depression Inventory II
-21 item __-___ measure
self-reported
Beck-Depression Inventory II
-advantage → more ___ than PHQ-9, includes __ and __ symptoms
detailed, cognitive, somatic
Beck-Depression Inventory II
-limitation → ___ than PHQ-9, copyright protected
-cut-off → score ≥__ indicates clinically significant depression
longer, 14
Beck-Depression Inventory II-Preferred Use
-___ studies
-____ psychological evaluations
-when there is need for ___ symptom assessment
research, comprehensive, detailed
Hamilton Depression Rating Scale (HAM-D)
-____-administered (not self-administered)
clinician
Hamilton Depression Rating Scale-Preferred Use
-used to measure ___ after depression is already established
-used often in clinical trials and psychiatric evaluations
-not a ___ tool
severity, diagnostic
Edinburgh Postnatal Depression Scale (EPDS)
-asks about depression symptoms over the past 7 days, with emphasis on ___ (inability to feel pleasure) rather than somatic symptoms)
anhedonia
Edinburgh Postnatal Depression Scale (EPDS)-Preferred Use
-during ___ (all 3 trimesters)
-___-___ weeks postpartum (universal screening recommended)
pregnancy, 4-6
Edinburgh Postnatal Depression Scale (EPDS)
-cut-off → score ≥__ indicates depression
-if positive response to question 10 (asks about suicide/self harm) → immediate ___ needed
10, referral
Screening tools for anxiety
1. generalized anxiety disorder 7 (___-__)
2. generalized anxiety disorder 2 (___-__)
GAD-7, GAD-2
GAD-7
-measures frequency of anxiety symptoms over the past 2 weeks
-score ≥__ indicates anxiety
10
GAD-7 Limitations
-doesn't ___ between specific anxiety subtypes
-may miss anxiety disorders with primarily ___ symptoms
distinguish, physical
GAD-7-Preferred Use
-screening for anxiety disorders in ___ ___
-patients with __ physical symptoms
-monitoring anxiety treatment ___
-patients with ___
primary care, unexplained, response, depression
GAD-2
-uses first 2 questions from GAD-7
-score ≥__ indicates possible anxiety and warrants full GAD-7
3
GAD-2-Preferred Use
-first-line screening in ___ clinical settings
-__ wellness exams
-paired with PHQ-2 for combined depression/anxiety screening
busy, annual
Screening tools for cognitive impairment
1. mini mental state examination (___)
2. montreal cognitive assessment (___)
3. brief interview for mental status (___)
MMSE, MOCA, BIMS
mini mental state examination (MMSE)
-performed by trained clinician
-domains: orientation, registration, attention, recall, language, visual construction
-score
24
MMSE-Preferred Use
-general screening
-___ comparison
historical
MMSE-Strengths
-___ used, well-studied
-good for general screening/tracking over time
widely
MMSE-Limitations
-less sensitive to ___ impairment, ___ dysfunction, and some ___-___ patterns
-affected by education, literacy, sensory impairments
early, executive, non-Alzheimer
montreal cognitive assessment (MOCA)
-performed by trained clinician
-domains: 8 cognitive domains (memory, attention, language, visuospatial, executive function)
-score
26
MOCA-Preferred Use
-early detection of ___
MCI
MOCA-Strengths
-designed to detect mild cognitive impairment ___ than MMSE
-____ cognitive coverage, includes executive and visuospatial tasks
earlier, broad
MOCA-Limitation
-requires trained clinical and formal __ in some settings
-____-consuming; may over-identify impairment if cutoffs applied rigidly
certification, time
brief interview for mental status (BIMS)
-structured interview (CMS/MDS 3.0 requirement for all ___ residents)
-domains: orientation and recall only
-cutoff
SNF, 8
BIMS-Preferred Use
-quick compliance check in ___
SNFs
BIMS-Strengths
-required by CMS for SNF cognitive screening
-___, requires minimal training for staff
quick
BIMS-Limitations
-limited ___ (does not assess other cognitive domains, does not assess behavioral/neurological issues)
-lower sensitivity for ___ cognitive impairment than MOCA/MMSE
scope, mild
Screening tools for alcohol use disorders
1. alcohol use disorders identification test (___)
2. ____: quick alcohol screening
AUDIT, CAGE
alcohol use disorders identification test (AUDIT)
-score ≥__ indicates hazardous drinking requiring intervention
8
AUDIT-Preferred Use
-annual screening in ___ ___
-before prescribing meds metabolized by ___
-for patients with liver disease, HTN, MDD, or sleep problems
-evaluating ___ for alcohol treatment
primary care, liver, readiness
There is a brief version of AUDIT called ___-__, which is only 3 questions
AUDIT-C
CAGE
-only 4 question
-score ≥__ suggest alcohol use disorder
2
CAGE- Preferred Use
-very ___ screening (30 seconds)
-when AUDIT is too lengthy
-identifying alcohol ___ specifically
quick, dependence
CAGE- Limitations
-less sensitive than AUDIT for detecting ___ hazardous drinking
early
bottom line
Use ___ for comprehensive screening
Use ___ for rapid screening of established drinkers
AUDIT, CAGE
Screening tools for psychotropic side effects-Patient Completed Scales
1. Glasgow Antipsychotic Side Effect Scale (____ Scale)
2. Systemic Monitoring of Adverse Events Related to Treatments (____)
GASS, SMARTS
Screening tools for psychotropic side effects-Clinician Rating Scales
1. Abnormal Involuntary Movement Scale (___)
2. Barnes Akathisia Rating Scale (___)
3. Simpson Angus Scale (___)
AIMS, ARS, SAS
Use AIMS to screen for ___ ___
tardive dyskinesia
Use ARS to screen for drug-induced ___
akathisia
Use SAS to quanitify drug-related ____, rigidity, and tremor
parkinsonism